James Sidoti
Stock Analyst at Sidoti & Co.
(3.02)
# 1,356
Out of 4,944 analysts
9
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $28.21 | -0.74% | 3 | Aug 5, 2025 | |
| SRDX Surmodics | Downgrades: Neutral | $43 | $38.03 | +13.07% | 1 | May 29, 2024 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $0.26 | +1,801.14% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $95.50 | -64.40% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $9.10 | +570.33% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $28.21
Upside: -0.74%
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $38.03
Upside: +13.07%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $0.26
Upside: +1,801.14%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $95.50
Upside: -64.40%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $9.10
Upside: +570.33%